Melexis Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Melexis de 7.3% y 7.2% por año respectivamente. Se prevé que el BPA crezca en un 7.3% al año. Se espera que la rentabilidad financiera sea de 36.5% en 3 años.

Información clave

7.0%

Tasa de crecimiento de los beneficios

7.0%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Semiconductor	18.3%
Tasa de crecimiento de los ingresos	7.5%
Rentabilidad financiera futura	34.6%
Cobertura de analistas	Good
Última actualización	01 May 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Melexis NV's (EBR:MELE) Intrinsic Value Is Potentially 20% Below Its Share Price

Apr 11

What Is The Ownership Structure Like For Melexis NV (EBR:MELE)?

Mar 17

Is Melexis (EBR:MELE) Likely To Turn Things Around?

Feb 28

Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?

Feb 15

Consider This Before Buying Melexis NV (EBR:MELE) For The 2.8% Dividend

Feb 01

Has Melexis NV's (EBR:MELE) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Jan 18

Previsiones de crecimiento de beneficios e ingresos

ENXTBR:MELE - Estimaciones futuras de los analistas y datos financieros pasados (EUR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	1,182	256	227	282	11
12/31/2025	1,080	227	207	269	11
12/31/2024	999	206	163	237	11
3/31/2024	978	211	-91	3	N/A
12/31/2023	964	209	-92	3	N/A
9/30/2023	938	212	-74	7	N/A
6/30/2023	909	204	-21	42	N/A
3/31/2023	881	199	132	184	N/A
12/31/2022	836	197	148	188	N/A
9/30/2022	779	178	158	194	N/A
6/30/2022	722	166	124	161	N/A
3/31/2022	672	152	105	140	N/A
12/31/2021	644	131	103	142	N/A
9/30/2021	625	122	95	132	N/A
6/30/2021	584	100	92	123	N/A
3/31/2021	525	76	80	109	N/A
12/31/2020	508	69	71	96	N/A
9/30/2020	487	61	72	95	N/A
6/30/2020	489	61	81	104	N/A
3/31/2020	509	67	75	101	N/A
12/31/2019	487	60	68	94	N/A
9/30/2019	501	73	67	105	N/A
6/30/2019	525	88	45	96	N/A
3/31/2019	547	101	35	98	N/A
12/31/2018	569	115	23	100	N/A
9/30/2018	560	114	5	78	N/A
6/30/2018	541	112	22	89	N/A
3/31/2018	527	114	45	106	N/A
12/31/2017	512	111	N/A	113	N/A
9/30/2017	499	109	N/A	116	N/A
6/30/2017	486	107	N/A	96	N/A
3/31/2017	470	99	N/A	108	N/A
12/31/2016	456	96	N/A	108	N/A
9/30/2016	439	93	N/A	116	N/A
6/30/2016	426	93	N/A	134	N/A
3/31/2016	415	95	N/A	127	N/A
12/31/2015	400	99	N/A	115	N/A
9/30/2015	386	97	N/A	109	N/A
6/30/2015	371	97	N/A	103	N/A
3/31/2015	351	93	N/A	97	N/A
12/31/2014	332	85	N/A	95	N/A
9/30/2014	319	81	N/A	95	N/A
6/30/2014	304	71	N/A	84	N/A
3/31/2014	289	63	N/A	80	N/A
12/31/2013	275	55	N/A	71	N/A
9/30/2013	262	56	N/A	57	N/A
6/30/2013	255	53	N/A	56	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (6% al año) de MELE es superior a la tasa de ahorro (1%).

Beneficios vs. Mercado: Se prevé que los beneficios (6% al año) de MELE crezcan menos que el mercado Belgian (16.1% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de MELE crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (7.3% al año) de MELE crezcan más rápidamente que los del mercado Belgian (5.9% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 7.3% al año) de MELE crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de MELE sea alta dentro de 3 años (36.5%)

Melexis Crecimiento futuro

Future controles de criterios 3/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target increased by 9.4% to €91.57

Melexis Provides Earnings Guidance for the Fourth Quarter and Full Year of 2022

Price target decreased to €82.38

Melexis NV Provides Sales Guidance for the First Quarter of 2022

Price target raised to €81.78

Recent updates

Investor sentiment improves as stock rises 16%

New minor risk - Share price stability

Full year 2023 earnings: EPS misses analyst expectations

Calculating The Fair Value Of Melexis NV (EBR:MELE)

At €78.60, Is Melexis NV (EBR:MELE) Worth Looking At Closely?

Many Would Be Envious Of Melexis' (EBR:MELE) Excellent Returns On Capital

Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations

Final dividend of €1.68 announced

Full year 2023 earnings: EPS misses analyst expectations

Melexis NV, Annual General Meeting, May 14, 2024

Melexis (EBR:MELE) Has A Pretty Healthy Balance Sheet

What Does Melexis NV's (EBR:MELE) Share Price Indicate?

Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors

Melexis (EBR:MELE) Knows How To Allocate Capital

Calculating The Intrinsic Value Of Melexis NV (EBR:MELE)

Now 22% undervalued after recent price drop

Third quarter 2023 earnings: EPS exceeds analyst expectations

Melexis NV to Report Q2, 2024 Results on Jul 31, 2024

Melexis' (EBR:MELE) Dividend Will Be €0.91

Upcoming dividend of €0.91 per share at 4.3% yield

Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91

Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?

Melexis (EBR:MELE) Has Announced A Dividend Of €0.91

Melexis (EBR:MELE) Has Announced A Dividend Of €0.91

Melexis' (EBR:MELE) Dividend Will Be €0.91

New major risk - Earnings quality

Second quarter 2023 earnings: EPS exceeds analyst expectations

Melexis (EBR:MELE) Might Become A Compounding Machine

Do Melexis' (EBR:MELE) Earnings Warrant Your Attention?

Estimating The Intrinsic Value Of Melexis NV (EBR:MELE)

Upcoming dividend of €1.54 per share at 5.0% yield

At €99.75, Is Melexis NV (EBR:MELE) Worth Looking At Closely?

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

With EPS Growth And More, Melexis (EBR:MELE) Makes An Interesting Case

Price target increased by 9.4% to €91.57

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

Melexis NV, Annual General Meeting, May 09, 2023

Is It Time To Consider Buying Melexis NV (EBR:MELE)?

Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors

Is Melexis NV (EBR:MELE) Expensive For A Reason? A Look At Its Intrinsic Value

Investor sentiment improved over the past week

Melexis NV to Report Q2, 2023 Results on Aug 02, 2023

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Melexis Provides Earnings Guidance for the Fourth Quarter and Full Year of 2022

Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91

Upcoming dividend of €0.91 per share

Melexis' (EBR:MELE) Dividend Will Be €0.91

Now 23% undervalued

Melexis' (EBR:MELE) Dividend Will Be €0.91

We Ran A Stock Scan For Earnings Growth And Melexis (EBR:MELE) Passed With Ease

Melexis' (EBR:MELE) Dividend Will Be €0.91

Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91

Melexis (EBR:MELE) Will Pay A Dividend Of €0.91

Melexis NV Announces Interim Dividend, Payable on October 18, 2022

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Price target decreased to €82.38

Is There An Opportunity With Melexis NV's (EBR:MELE) 31% Undervaluation?

Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns

Now 22% undervalued after recent price drop

Does Melexis (EBR:MELE) Deserve A Spot On Your Watchlist?

Upcoming dividend of €0.91 per share

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Less than half of directors are independent

Should You Think About Buying Melexis NV (EBR:MELE) Now?

Calculating The Fair Value Of Melexis NV (EBR:MELE)

Melexis NV Provides Sales Guidance for the First Quarter of 2022

Melexis NV, Annual General Meeting, May 10, 2022

Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns

Should You Think About Buying Melexis NV (EBR:MELE) Now?

Third quarter 2021 earnings released: EPS €0.90 (vs €0.37 in 3Q 2020)